Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Lab-on-a-Chip and Microfluidics Asia 2022

Yoshinobu Baba's Biography

Yoshinobu Baba, Professor, Nagoya University

Dr. Yoshinobu Baba is Professor of Department of Applied Chemistry, Graduate School of Engineering, Nagoya University. He is also a Director of FIRST Research Center for Innovative Nanobiodevices, Nagoya University and a Director of Synchrotron Radiation Research Center, Nagoya University. He is an Associate Editor of Anal. Chem. of American Chemical Society and serving to over 20 scientific journals, including Nanoscale of Royal Society of Chemistry and Biomicrofluidics of American Institute of Physics, as an editorial/advisory board member. He is a co-initiator for the world largest Nanotech/Nanobio International Meeting and Exhibition in Japan and International Academy of Nanomedicine. He is a general chair of numerous international meetings (microTAS, MSB, NanoBioEXPO, ISMM). He has been admitted as a Fellow of the Royal Society of Chemistry and received over 113 awards for his contributions in nanobiotechnology: MERCK Award in 2004, award from the Applied Physics Society of Japan in 2006, and The CSJ (Chemical Society of Japan) award for creative work in 2008. His major area of interest is nanobiosicence and nanobiotechnology for omics, systems biology, medical diagnosis, tissue engineering, and molecular imaging. He is the author or co-author of 767 publications, including research papers, proceedings, reviews, and books and is also an inventor of over 70 patents. He has delivered more than 726 plenary and invited lectures at conferences. His work has been cited on 299 occasions by newspapers and televisions.

Yoshinobu Baba Image

Nanobiodevices, Quantum Technology, and AI for Future Healthcare

Thursday, 6 October 2022 at 09:00

Add to Calendar ▼2022-10-06 09:00:002022-10-06 10:00:00Europe/LondonNanobiodevices, Quantum Technology, and AI for Future HealthcareLab-on-a-Chip and Microfluidics Asia 2022 in Tokyo, JapanTokyo,

We have developed nanobiodevices, quantum technology, and AI for biomedical applications and healthcare, including single cancer cell diagnosis for cancer metastasis, circulating tumor cell (CTC) detection by microfluidic devices, nanopillar devices for ultrafast analysis of genomic DNA and microRNA, nanopore devices for single DNA and microRNA sequencing, nanowire devices for exosome analysis, single-molecular epigenetic analysis, AI-powered nano-IoT sensors, quantum switching intra vital imaging of iPS cells and stem cells, and quantum technology-based cancer theranostics. Immuno-wall microfluidic devices realized the fast and low invasive “from blood to analysis” type biomarker detection of cancer with fM detection sensitivity within 2 min.  Additionally, nanopillar nanofluidic devices give us ultrafast separation of DNA and microRNA within 60 µs and nanopillar-nanopore integrated nanobiodevice enables us ultrafast single molecular DNA sequencing.  Nanowire devices are extremely useful to isolate extracellular vesicles from body fluids and vesicle-encapsulated microRNA analysis.  The device composed of a microfluidic substrate with anchored nanowires gives us highly efficient collections of extracellular vesicles in body fluids and in situ extraction for huge numbers of miRNAs (2,500 types) more than the conventional ultracentrifugation method. Nanowire devices gave us the miRNA date for several hundred patients and machine learning system based on these miRNA data enabled us to develop the early-stage diagnosis for lung cancer, brain tumor, pancreas cancer, liver cancer, bladder cancer, prostate cancer, diabetes, heart diseases, and Parkinson disease.  Nanowire-nanopore devices combined with AI (machine learning technique) enable us to develop mobile sensors for SARA-CoV-2, PM2.5, bacteria, and virus in the environment.  Quantum dots and nanodiamonds with nitrogen-vacancy centers are applied to develop quantum-biodevices for single cancer cell diagnosis, single molecular epigenetic analysis, quantum switching intra vital imaging for iPS cell (induced pluripotent stem cells) based regenerative medicine, and quantum photo immuno-therapeutic devices for cancer.

Add to Calendar ▼2022-10-06 00:00:002022-10-07 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics Asia 2022Lab-on-a-Chip and Microfluidics Asia 2022 in Tokyo, JapanTokyo,